Porphobilinogen synthase deficiency
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Porphobilinogen synthase deficiency
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
ALAD porphyria is a recessive disorder; there are two common variant ALAD alleles, which encode K59 and N59, and eight known porphyria-associated ALAD mutations, which encode F12L, E89K, C132R, G133R, V153M, R240W, A274T, and V275M.
|
17236137 |
2007 |
Porphobilinogen synthase deficiency
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
ALAD porphyria is a recessive disorder; there are two common variant ALAD alleles, which encode K59 and N59, and eight known porphyria-associated ALAD mutations, which encode F12L, E89K, C132R, G133R, V153M, R240W, A274T, and V275M.
|
17236137 |
2007 |
Porphobilinogen synthase deficiency
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
delta-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations.
|
16343966 |
2006 |
Porphobilinogen synthase deficiency
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Only four bona fide cases of Doss porphyria have been reported to date that were confirmed by immunological and molecular analyses of their ALAD mutations.
|
15303011 |
2004 |
Porphobilinogen synthase deficiency
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
Novel molecular defects of the delta-aminolevulinate dehydratase gene in a patient with inherited acute hepatic porphyria.
|
10706561 |
2000 |
Porphobilinogen synthase deficiency
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Novel molecular defects of the delta-aminolevulinate dehydratase gene in a patient with inherited acute hepatic porphyria.
|
10706561 |
2000 |
Porphobilinogen synthase deficiency
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Cloning and expression of the defective genes in delta-aminolevulinate dehydratase porphyria: compound heterozygosity in this hereditary liver disease.
|
1309003 |
1992 |
Porphobilinogen synthase deficiency
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Cloning and expression of the defective genes from a patient with delta-aminolevulinate dehydratase porphyria.
|
1569184 |
1992 |
Porphobilinogen synthase deficiency
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
delta-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote.
|
2063868 |
1991 |
Porphobilinogen synthase deficiency
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
delta-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote.
|
2063868 |
1991 |
Porphobilinogen synthase deficiency
|
0.730 |
GermlineCausalMutation
|
disease |
ORPHANET |
delta-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote.
|
2063868 |
1991 |
Porphobilinogen synthase deficiency
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Porphobilinogen synthase deficiency
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Porphobilinogen synthase deficiency
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
Porphobilinogen synthase deficiency
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Lead Poisoning
|
0.500 |
Biomarker
|
disease |
CTD_human |
Investigation of delta-aminolevulinic acid dehydratase polymorphism affecting hematopoietic, hepatic and renal toxicity from lead in Han subjects of southwestern China.
|
24631795 |
2014 |
Liver Cirrhosis
|
0.500 |
Biomarker
|
disease |
CTD_human |
Characterization of chemically induced liver injuries using gene co-expression modules.
|
25226513 |
2014 |
Lead Poisoning
|
0.500 |
Biomarker
|
disease |
CTD_human |
Lead concentration in plasma as a biomarker of exposure and risk, and modification of toxicity by δ-aminolevulinic acid dehydratase gene polymorphism.
|
23792432 |
2013 |
Lead Poisoning
|
0.500 |
Biomarker
|
disease |
CTD_human |
The difference in methylation frequencies between exposures and controls was statistically significant (p=0.002), and individuals with methylated ALAD gene showed an increased risk of lead poisoning (adjusted OR=3.57, 95% CI, 1.55-8.18).
|
21396434 |
2011 |
Lead Poisoning
|
0.500 |
Biomarker
|
disease |
RGD |
Oral supplementation of gossypin during lead exposure protects alteration in heme synthesis pathway and brain oxidative stress in rats.
|
19647414 |
2010 |
Visual seizure
|
0.500 |
Biomarker
|
disease |
CTD_human |
Lipoic acid alters delta-aminolevulinic dehydratase, glutathione peroxidase and Na+,K+-ATPase activities and glutathione-reduced levels in rat hippocampus after pilocarpine-induced seizures.
|
19798568 |
2010 |
Visual seizure
|
0.500 |
Biomarker
|
disease |
RGD |
Involvement of oxidative stress in seizures induced by diphenyl diselenide in rat pups.
|
17320826 |
2007 |
Lead Poisoning
|
0.500 |
Biomarker
|
disease |
RGD |
Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats.
|
16597373 |
2006 |
Porphyrias, Hepatic
|
0.500 |
Biomarker
|
group |
CTD_human |
Hereditary hepatic porphyria due to homozygous delta-aminolevulinic acid dehydratase deficiency: studies in lymphocytes and erythrocytes.
|
1905639 |
1991 |